Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker
- 11 October 2005
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 132 (1) , 45-50
Abstract
Several studies have reported conflicting results regarding correlations of the loss of Fhit expression with clinicopathological parameters in gastric cancer. We investigated the immunohistochemical expression of Fhit in 362 cases of sporadic advanced gastric adenocarcinoma. The series included 64 cases with microsatellite instability associated with defective mismatch repair genes. Fhit expression resulted absent in 72% of the tumors analyzed. Absence of Fhit expression was more frequent in cases with diffuse and mixed histotype compared to the intestinal histotype (P=0.009). Absence of Fhit expression also correlated with tumor stage (PPP=0.033), and increasing histological grade (P=0.005). Retained Fhit expression also correlated with microsatellite instability as 61% of instable tumors had lost Fhit expression compared to 74% of microsatellite stable cancers (P=0.050). While loss of Fhit correlates with poorer survival in univariate analysis, it is not an independent prognostic factor in multivariate analysis and is thus not of clinical utility.Keywords
This publication has 29 references indexed in Scilit:
- Inactivation of the FHIT Gene Favors Bladder Cancer DevelopmentClinical Cancer Research, 2004
- Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancerEuropean Journal of Cancer, 2004
- Regression of upper gastric cancer in mice by FHIT gene deliveryThe FASEB Journal, 2003
- Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinomaEuropean Journal of Gastroenterology & Hepatology, 2003
- Tumour suppressor gene expression correlates with gastric cancer prognosisThe Journal of Pathology, 2003
- Characterization of aberrant FHIT transcripts in gastric adenocarcinomasExperimental & Molecular Medicine, 2001
- The tumor spectrum in FHIT- deficient miceProceedings of the National Academy of Sciences, 2001
- Altered Expression of the Fragile Histidine Triad Gene in Primary Gastric AdenocarcinomasBiochemical and Biophysical Research Communications, 2001
- The FHIT Gene at 3p14.2 Is Abnormal in Lung CancerCell, 1996
- Fhit, a Putative Tumor Suppressor in Humans, Is a Dinucleoside 5‘,5‘ ‘‘-P1,P3-Triphosphate HydrolaseBiochemistry, 1996